510(k) Report

510(k) · Cleared

Cleared

VirtuOst Vertebral Fracture Assessment

K171435510(k) TraditionalCleared Aug 3, 2018445-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

O.N. Diagnostics, LLC · LLZ System, Image Processing, Radiological

Cleared on Aug 3, 2018 as substantially equivalent to K103475 (Optasia Medical, 2011) and 1 other predicate after a 445-day review. Its family tree reaches back 3 generations to 1995.

Decided
Aug 3, 2018
Review
445 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K950611 (1995). 5 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2000: 1 other ancestor1999: 1 other ancestorK950611 · Expert Morphomerty Softward · Lunar Corp. · 1995K023554 · Dual-Energy Vertebral Assessment View Software · Ge Lunar Corp. · 2002K103475 · Spineanalyer Model Sapoc · Optasia Medical · 2011199520002005201020152020
  1. Root · 3 generations backK950611 Expert Morphomerty SoftwardLunar Corp. · 1995
  2. 2 generations backK023554 Dual-Energy Vertebral Assessment View SoftwareGe Lunar Corp. · 2002
  3. 1 generation backK103475 Spineanalyer Model SapocOptasia Medical · 2011
  4. This deviceK171435 VirtuOst Vertebral Fracture AssessmentO.N. Diagnostics, LLC · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K950611Expert Morphomerty SoftwardLunar Corp.1995—
−2K023554Dual-Energy Vertebral Assessment View SoftwareGe Lunar Corp.2002—
−1K103475Spineanalyer Model SapocOptasia Medical2011—
0 (this device)K171435VirtuOst Vertebral Fracture AssessmentO.N. Diagnostics, LLC2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
FIG. 1 — Lineage of K171435, 1995–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K103475Spineanalyer Model Sapoc
Summary page 4
…Bone Densitometer Secondary Regulation Number: 21 CFR 892.1170 Secondary Product Code: KGI 3) Identification of Predicate Devices K103475: SpineAnalyzer Company: Optasia Medical Primary Classification N…
Optasia Medical2011—
*K023554Dual-Energy Vertebral Assessment View Software
Summary page 4
…ation Name: Picture archiving and communications system Primary Regulation Number: 21 CFR 892.2050 Primary Product Code: LLZ K023554: Dual-Energy Vertebral Assessment View Software Option Company: GE L…
Ge Lunar Corp.2002—

Also cleared against K103475: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 4 companies; a new generation was cleared every 7.6 years on median.
  • None of the 5 ancestors has a recall.
  • 1 other device also cites its predicate K103475.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

VirtuOst VFA uses sagittal sections from a spine-containing CT scan, with or without contrast enhancement, to visualize and measure vertebral deformities, classify the type and grade of any existing vertebral fracture, and from this identify patients at high risk of a future osteoporosis-related fracture. This information can be interpreted by a physician to diagnose existing vertebral fractures and to manage patients for osteoporosis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K171435: VirtuOst Vertebral Fracture Assessment.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K171435

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026